04/02/2024 4:00 PM | AbbVie (Issuer) RAPP EDWARD J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 4:00 PM | AbbVie (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 4:00 PM | AbbVie (Issuer) Quaggin Susan E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 1:31 PM | AbbVie (Subject) Chevedden John (Filed by)
| Form PX14A6G | |
03/22/2024 4:00 PM | AbbVie (Issuer) Donoghoe Nicholas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 1:29 PM | AbbVie (Subject) Donoghoe Nicholas (Reporting)
| Form 144/A | |
03/20/2024 6:30 PM | AbbVie (Subject) Donoghoe Nicholas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/20/2024 4:00 PM | AbbVie (Issuer) Stewart Jeffrey Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 3:27 PM | AbbVie (Filer)
| Form ARS | |
03/05/2024 4:30 PM | AbbVie (Issuer) RICHMOND TIMOTHY J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:53 PM | AbbVie (Subject) Reents Scott T (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:50 PM | AbbVie (Issuer) GONZALEZ RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Donoghoe Nicholas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Thakkar Roopal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Hudson Thomas J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) RICHMOND TIMOTHY J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) SALEKI-GERHARDT AZITA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Stewart Jeffrey Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Siatis Perry C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Michael Robert A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Buckbee Kevin K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:50 PM | AbbVie (Issuer) Reents Scott T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 3:20 PM | AbbVie (Subject) RICHMOND TIMOTHY J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 5:06 PM | AbbVie (Subject) Buckbee Kevin K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:33 PM | AbbVie (Subject) Michael Robert A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:00 PM | AbbVie (Issuer) GONZALEZ RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 4:52 PM | AbbVie (Subject) GONZALEZ RICHARD A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 5:12 AM | AbbVie (Filer)
| Form 424B5 | |
02/23/2024 4:00 PM | AbbVie (Issuer) SALEKI-GERHARDT AZITA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 8:14 PM | AbbVie (Subject)
| Form FWP | |
02/21/2024 5:00 PM | AbbVie (Subject) SALEKI-GERHARDT AZITA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 7:39 AM | AbbVie (Filer)
| Form 424B5 | |
02/20/2024 4:23 PM | AbbVie (Issuer) SALEKI-GERHARDT AZITA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 11:45 AM | AbbVie (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2024 8:00 AM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:49 AM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2024 4:00 PM | AbbVie (Issuer) Siatis Perry C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 4:50 PM | AbbVie (Subject) Siatis Perry C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 6:51 AM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2024 3:59 PM | AbbVie (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/03/2024 4:17 PM | AbbVie (Issuer) Quaggin Susan E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Incredible Opportunity to Retire FAST! (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
01/03/2024 4:08 PM | AbbVie (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:00 PM | AbbVie (Issuer) Donoghoe Nicholas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:02 PM | AbbVie (Subject) Donoghoe Nicholas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 4:28 PM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 7:47 AM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2023 12:32 PM | AbbVie (Subject) NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
11/06/2023 12:01 PM | AbbVie (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023 6:49 AM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 4:04 PM | AbbVie (Issuer) Quaggin Susan E (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/19/2023 4:06 PM | AbbVie (Issuer) Davis Jennifer L. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/12/2023 4:17 PM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 3:11 PM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2023 4:00 PM | AbbVie (Issuer) GONZALEZ RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 4:00 PM | AbbVie (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2023 3:01 PM | AbbVie (Subject) GONZALEZ RICHARD A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023 3:04 PM | AbbVie (Subject) GONZALEZ RICHARD A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/27/2023 6:45 AM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 4:04 PM | AbbVie (Issuer) Donoghoe Nicholas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/06/2023 3:18 PM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2023 4:00 PM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 4:00 PM | AbbVie (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
05/05/2023 11:54 AM | AbbVie (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 7:08 AM | AbbVie (Subject) ZEVIN ASSET MANAGEMENT LLC (Filed by)
| Form PX14A6G | |
04/27/2023 4:00 PM | AbbVie (Issuer) Sorg Elaine K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/27/2023 6:36 AM | AbbVie (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2023 3:16 PM | AbbVie (Subject) AbbVie (Subject) Sorg Elaine K. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |